Malaria parasite genes can exhibit variation in sequence or transcriptional activity. A wealth of information is available on sequence polymorphism in clinical malaria isolates, but there are few quantitative whole-transcriptome studies of natural variation at specific developmental stages. It is challenging to obtain adequately precise and well-replicated transcriptome measurements in order to account for technical and biological variation among preparations, which can otherwise introduce noise or bias in analyses. We address the issue by obtaining of RNA-seq profiles of multiple independently cultured replicates of mature schizont-stage malaria parasites from a panel of clinical isolates and laboratory-adapted lines. With a goal of robustly identifying variably expressed genes, we show that increasing the biological sample replication improves the true positive discovery rate, and that six independent replicates of each isolate is significantly superior to lower numbers. Focusing on genes that are more highly expressed on average improves the discovery rate when fewer biological replicates are available. We identify genes encoding transcription factors and proteins implicated in gametocytogenesis that differ in expression between cultured clinical and laboratory adapted lines.
Introduction
Symptoms of malaria occur as the malaria parasite undergoes cycles of invasion and replication inside erythrocytes. Towards the end of each intra-erythrocytic cycle of cell division, 'schizont'-stage malaria parasites upregulate the expression of genes encoding proteins that contribute to daughter cell ('merozoite') egress and invasion of a new host cell. Despite the highly controlled transcriptional program throughout the parasite life-cycle [1] , transcriptional variation exists between parasite clones [2, 3] , and can also be induced by external cues [4] [5] [6] [7] . In P. falciparum, variable expression of members of the var gene family, which encode hypervariable Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens, leads to extensive antigenic variation [8] . However, the extent to which gene expression variation contributes to the diversity of other antigens is not known.
Merozoite-stage antigens are also targets of acquired immunity [9] and antibodies against many merozoite antigens are correlated with protection from malaria [10] . Analysis of genome sequences from clinical P. falciparum isolates has shown that directional selection by acquired immune responses [11] [12] [13] [14] has led to the evolution of multiple alleles of many merozoite antigens.
Nonetheless, merozoite antigens do not exhibit sequence diversity to the extent of gene families such as var, rifin [15] or stevor [16] , and therefore are appealing targets for vaccination. In addition to allelic diversity, many merozoite antigens exhibit variable expression patterns [11, [17] [18] [19] . While whole-genome sequencing studies of clinical and laboratory-adapted parasite isolates have provided a wealth of information contributing to our understanding of diversity among immune antigens and adaptive traits such as transmission, the extent of antigenic diversity cause by schizont-stage transcriptional plasticity has not been studied at the whole-transcriptome level. Antigenic diversity caused by variations in gene expression must be characterised so that we can understand features of parasite virulence such as adaptation and immune evasion.
Accurate quantitation of differential gene expression in whole-transcriptome analyses is affected by the level of biological replication within sample groups [20, 21] . In the absence of biological replication, it is impossible to account for variation that exists due to the stochasticity of gene expression [21] . The impact of sample replication on the detection of differential gene expression has been the focus of much research [22] , and bioinformatics tools have been developed to determine replicate numbers appropriate to experimental designs [23, 24] . In transcriptomic studies of malaria parasites, life-cycle stage, overall synchronicity and gametocyte conversion are technically challenging to replicate [2, 25] . Continuous epigenetic switching of large numbers of genes also creates transcriptional diversity within genetically clonal parasite populations [3] . These features of parasite biology can confound the transcript profile of a given sample and contribute to apparent genewise expression variation among samples. Approaches to mitigate the effect of life-cycle length and staging have involved sampling isolate transcriptomes throughout the parasite life-cycle [2, 26] .
However, no large-scale studies into malaria parasite transcriptomes have been undertaken that include independent biological replication to allow adjustment for gene-wise variation within samples.
Much of our understanding of malaria parasite biology is derived from parasite lines that have been adapted to in vitro culture for decades [27] [28] [29] [30] . Genome sequencing studies have identified polymorphisms in transcriptional factors and cell signalling proteins [31, 32] , as well as genetic deletions and amplifications [33, 34] that are associated with adaptation of parasites to in vitro culture.
While laboratory-adapted isolates are antigenically and transcriptionally diverse [3, 17, 26, 35, 36] , it is not clear to what extent they reflect the diversity among ex vivo parasites. Therefore, ex vivo clinical isolates analysed in the first cycle of growth following isolation from an infected person are the most relevant parasites for the study of in vivo phenotypes such as growth rate and antigenic variation. Ex vivo isolates matured to the schizont stage show variations in expression of immunologically relevant genes encoding proteins with roles to merozoite invasion [11, 18, 19] .
However, ex vivo isolates are not replicable, and are often not available in sufficient quantities for whole transcriptomic analysis. Furthermore, despite efforts to adapt ex vivo isolates to in vitro culture [37] , in vitro-adapted cultured clinical lines may lose in vivo characteristics throughout the process of culture adaptation. Therefore, research to capture the extent of variation of the malaria parasite antigenic repertoire must compare multiple independent isolates, including laboratory-adapted isolates, and cultured and ex vivo clinical isolates, with a caveat of limited replicability for the latter.
Here we present gene expression profiles of schizont-stage malaria parasites from multiple cultured clinical isolates and laboratory-adapted lines. We conduct RNA-seq analysis with large numbers of replicates per sample, in order to minimise the impact of biological variation, and to generate highly resolved expression profiles of schizont-stage parasites. We show that increased replication within samples improves the true-positive discovery rate for identifying differentially expressed genes. We identify schizont-stage genes that are differentially expressed between laboratory-adapted and cultured clinical isolates, as well as genes variably expressed among cultured clinical isolates. We identify a set of putative merozoite antigens that show variable expression among cultured clinical isolates. We show that the expression levels of these genes in a panel of ex vivo clinical isolates are within the ranges of expression observed for laboratory-adapted and cultured clinical isolates. These data highlight the value of in vitro cultured parasite lines as proxy for ex vivo expression profiles.
Results

Generation of replicated, highly correlated schizont-stage transcriptomes from laboratory-adapted and cultured clinical isolates
Multiple replicates of schizont-stage parasites from four laboratory-adapted P. falciparum lines (3D7, Dd2, D10 and HB3) and six recently culture-adapted P. falciparum clinical isolates from Navrongo, Ghana (INV271, INV278, INV280, INV286, INV293 and INV296) were isolated by either MACS or discontinuous density centrifugation (Percoll) methods. Since our cultured clinical isolates could not be consistently or reproducibly synchronised, we incubated parasite preparations with the egress inhibitor, E64, to block parasites at the schizont stage, in order to improve the yield of schizont-stage parasites and improve the resolution of parasite transcriptomes at this stage. Transcriptomes of the laboratory-adapted and cultured clinical isolates were generated by RNA sequencing (RNA-seq).
RNA-seq analysis of four paired replicates of E64-treated and untreated P. falciparum 3D7 cultures showed that E64 treatment per se did not affect the transcriptomes; only a single gene was differentially expressed by log 2 fold change > 2 (S1 File).
Gene expression differences between parasite isolates have previously been shown to be affected by genetic changes such as copy-number variations and polymorphisms that impact on the quantitation of transcripts when counted with respect to a reference strain genome such as 3D7 [2] . To minimize the impact of inter-isolate sequence differences on gene expression measures, we generated a highly curated gene annotation file for RNA-seq read mapping that excluded regions of putative or known polymorphism (S2 file). As such, only reads mapping to non-polymorphic portions of polymorphic genes were used in quantitative expression analysis. We did not remove genes for which deletions were known from any of our analyses, as this would have resulted in an entire loss of data for genes that are absent only in subsets of isolates. Table) . Replicates were excluded that did not have a maximum Spearman's correlation with parasites at 40 or 48 hours post-invasion. After this filtering step, each laboratory-adapted isolate was represented by at least six independently prepared replicates, and each cultured clinical isolate was represented by at least three independently prepared replicates (summarised in Table 1) . Table) .
Sample replication improves detection of differentially expressed genes
Transcriptomic comparisons of sample groups containing in excess of 40 replicates per group have shown that the sensitivity for detecting differential expression of genes between groups increases with the number of replicates in each group [22] . We assessed the impact of increasing replication by comparing our 3D7 (prepared with Percoll) and D10 sample groups, which each contained ten
replicates. Differential expression analysis comparing the full 10 replicate groups of 3D7 and D10
identified 123 differentially expressed genes (absolute log 2 fold change > 2, an adjusted P-value < 0.01). This number may increase with additional replication. However, this level of replication is rarely practical, particularly when handling rare or sensitive isolates. To identify an optimal level of replication that balances transcript discovery with achievable replicate numbers, we assessed what proportion of the 123 genes from the 10 replicate dataset were captured through comparisons that used two, four, six and eight replicates within each group. The true-positive rate of genes detected for 100 comparisons (using randomly selected replicates from each sample group) increased with the number of replicates within each group; the median true-positive rates were 0.30, 0.50, 0.67 and 0.80, when two, four, six and eight replicates were included, respectively (Fig 1) . While the true-positive rate of genes detected increased with the number of replicates, the false-positive rate remained low irrespective of the number of replicates included (Fig 1) .
We also determined the true-positive rate for detecting differential expression among the most highly expressed schizont-stage genes. For each of the 100 comparisons, replicate FPKMs for each sample were averaged to give 'per-sample' FPKM expression values and the genes with non-zero FPKM values were ranked by their maximum expression level in either strain. For each comparison, we determined the differentially expressed genes that fell within the top quartile of most highly expressed genes, and compared these to the differentially expressed genes identified among the top quartile of genes in the full (two x 10 replicate) analysis. Through analysis of differential expression among genes in the top quartile of expression levels, an improved true-positive rate was observed for replicate numbers tested. A median true-positive rates of 0.45, 0.63, 0.78 and 0.86 were achieved for comparisons containing two, four, six and eight replicates, respectively. Based on these data, we advocate the use of six independent biological replicates. Fewer replicates can be tolerated when analyses are focussed on the most highly expressed genes.
Comparison of gene expression in cultured clinical and laboratory-adapted isolates.
Pressures experienced by malaria parasites in vivo, such as immune selection, nutrient availability and febrile episodes, select for parasites with particular transcriptomic characteristics [3, 17] . In vitro, these pressures are minimised, therefore transcriptomic comparisons of laboratory-adapted and clinical isolates can explain phenotypic differences that occur through the process of culture adaption
[2], such as the use of distinct invasion pathways [39] . We used our combined data for laboratoryadapted and cultured clinical strains to identify schizont-stage genes that change in expression through adaptation to in vitro culture. In an analysis comparing the transcriptomes of laboratory and cultured clinical isolates, allowing for differences in purification method, one hundred and thirty four genes were identified as being differentially expressed between the two groups (S1 Fig and S3 Table) across all fourteen chromosomes (Fig 2a) , representing 2.6 % of genes within the analysis. Within the top quartile of gene expression values (genes with a log 2 FPKM value of > 6.94), twenty genes were significantly differentially expressed between the laboratory-adapted and clinical isolate groups (Fig   2b and S3 Table) , representing 1.6 % of genes in the top quartile. This indicates a slight over representation of differentially expressed genes in the lower 75 % of gene expression values (Fisher's exact test odds ratio 0.518, P-value 0.006), which may reflect an inflated number of differentially expressed genes among these genes, due to false positives among low-expressed genes. After exclusion of genes for which the differential expression was likely as a result of known genetic deletions, and others belonging to sub-telomeric multi-gene families (S3 Table) , twelve genes were identified as showing strong signals of differential expression between laboratory and clinical isolates (Table 2) . The distinct expression levels of the genes differentially expressed between the laboratory-adapted and cultured clinical isolate groups (Table 2) is apparent through analysis of the normalised read counts for each gene (Fig 2b) . Differences in expression were largely consistent across all isolates within each group (Fig 2b) . This was despite low counts for PF3D7_1371600 (EBL-1) and PF3D7_0935700 in the HB3 strain and D10 strain, respectively, due to previously documented deletions [46, 47] , that were nonetheless upregulated in laboratory isolates. genes were differentially expressed (log 2 fold change >2 and adjusted P-value < 0.01) among those genes in the top quartile of schizont-stage gene expression (log 2 FPKM > 7.42; Fig 3a) . A group of 20 genes showed exceptionally high log 2 fold changes (outliers , Fig 3b) , up to a maximum of 14.42 (Fig 3b) . These highly differentially expressed genes also contributed to the largest mean fold changes in gene expression among the laboratory-line comparisons (Fig 3c) . Further investigation confirmed that differential expression of the majority of these genes may be explained by genomic differences between strains (S5 Table) . For example, 13 genes in close proximity on chromosome 9
appear strongly down-regulated in the D10 strain (Fig 3d) , in keeping with previously documented deletions in this region of chromosome 9 for this strain [33] .
These data reiterate the importance of considering genetic differences between strains when making transcriptomic comparisons involving long-term laboratory adapted lines, and demonstrate how the use of multiple strains can minimise the impact of CNVs on studies of culture adaptation.
Differential expression among schizont-stage genes in cultured clinical isolates
To focus on differentially expressed genes among cultured clinical isolates without the impact of strong signals of differential expression due to genomic differences among laboratory strains, we analysed the replicated RNA-seq data for the cultured clinical samples in pairwise combinations.
Among the fifteen pairwise comparisons, two hundred and fourteen genes showed an absolute log 2 fold change > 2 with an adjusted P-value < 0.01. Since the sample sizes for three of the six isolates contained fewer than six replicates each, these data may be an under-estimate of the true extent of differential expression. However, this was deemed preferable to inclusion of replicates with poor correlation to either the other replicates for that sample, or to overall schizont-stage transcriptomes.
Differentially expressed genes among the top quartile of gene expression values were further analysed, in order to focus on the most highly expressed schizont-stage genes and to maximise the discovery rate given than some samples contained as few as three replicates. Replicate FPKMs were averaged to give 'per-sample' FPKM expression values. Of those genes in the top quartile of expression levels (log 2 FPKM > 6.34; Fig 4a) , thirty-nine genes were differentially expressed (Fig 4b and S4 Table) . The highest observed log 2 fold change was 13.51 (Fig 4c) .
A feature of the genes differentially expressed among cultured clinical isolates were differences in expression of merozoite invasion ligands. The genes encoding the erythrocyte binding antigens, EBA-140, EBA-175 and EBA-181, exhibited significant differential expression between isolates (S4 Table) . These genes are among a panel of invasion ligand genes that were previously investigated for
transcript-level variation in ex vivo clinical isolates [19] (S2 Fig).
Members of the merozoite-surface protein 3 family also showed variation in expression levels (S4 Table) including PF3D7_1036300, which encodes the duffy binding-like merozoite surface protein MSPDBL2, which was also differentially expressed when broadly comparing laboratory and cultured clinical isolates, in keeping with the highly variable expression levels documented for this gene [11] .
While fewer genes were differentially expressed among cultured clinical samples than laboratoryadapted isolates, there was significant overlap in the genes differentially expressed in comparisons among laboratory-adapted isolates and comparisons among cultured clinical isolates. Of the genes differentially expressed in comparisons among cultured clinical samples, 64 % were also differentially expressed in comparisons among laboratory-adapted lines (Fisher's exact test odds ratio 17.37, Pvalue < 2.2 x 10 -16 ; S4 Table) . This was also the case when only considering genes in the top quartile of expression values; 43.6 % of genes differentially expressed in comparisons among cultured clinical isolates were also differentially expressed in comparisons among laboratory-adapted isolates (Fisher's exact test odds ratio 7.94, P-value 2.4 x 10 -08
). This indicates that signals of variable gene expression in cultured clinical isolates are also captured through analysis of laboratory-adapted lines.
To validate the data obtained through RNA-seq, we identified a refined subset of genes for quantitation by reverse-transcription quantitative PCR (RT-qPCR). Since expression variation may be a mechanism of immune evasion, we focussed further validation on a subset of the differentially expressed genes encoding proteins that are likely to enter the parasite secretory pathway (either by virtue of transmembrane domains or signal peptides), since relevant targets of immunity are located at the parasite surface, or secreted during the process of invasion. We did not further validate genes that had received previous functional characterisation, or that were members of sub-telomeric multi-gene families (S4 Table) . In all, eight genes were identified for further characterisation (Table 3) , which included three genes that were also differentially expressed among laboratory-adapted isolate comparisons (PF3D7_0423900, PF3D7_1252900 and PF3D7_1476500). Putative merozoite surface proteins encoded by PF3D7_0102700 (merozoite-associated tryptophan-rich antigen, MaTrA [48]) and PF3D7_0220000 (liver-stage antigen-3, LSA-3 [49]), were also among the subset of genes identified for further characterisation. *Also differentially expressed among comparisons of transcriptomes of laboratory-adapted schizonts # Number of predicted transmembrane domains RT-qPCR assays were designed for absolute quantitation of these eight target genes. The transcripts of these eight genes were quantified by RT-qPCR for 58 of the 71 RNA preparations previously analysed by RNA-seq. Transcript copy numbers normalised to a house-keeping gene (HKG; PF3D7_0717700, serine-tRNA ligase) were correlated with HKG-normalised FPKM expression values for the same RNA preparations. With the exception of PF3D7_0935300, all genes showed a strong positive correlation between RNA-seq and RT-qPCR-derived expression measures (Fig 5) .
PF3D7_0935300 showed a weaker (r = 0.46) positive correlation.
Together these demonstrate the concordance of RNA-seq-derived and RT-qPCR-derived expression measures for these genes.
Expression of key variable genes in unreplicated ex vivo clinical isolates
Having robustly detected a panel of genes differentially expressed among cultured clinical isolates, we determined the expression levels of these genes in schizont-stage ex vivo clinical isolates (detailed in S6 Table) . RNA-seq libraries were generated for nine ex vivo clinical isolates (INV018, INV020 falciparum 3D7 time-course at earlier that 40 hours post-invasion, and were therefore not further analysed (Fig 6a) . We also identified six ex vivo isolates for quantification by RT-qPCR. These isolates were selected based on them having at least 50 % schizonts in the culture, of which at least 50 % had more than six nuclei. RNA-sequenced isolates INV018 and INV060 were also quantified by RT-qPCR.
RNA-seq and RT-qPCR expression values for the eight gene panel (Table 3) were normalised against respective expression values for the house-keeping gene, PF3D7_0717700. The ex vivo samples were distributed within the range observed for the laboratory-adapted and cultured clinical parasite samples (Fig 6b) . Without replication, the impact of biological variation the expression levels of these genes in ex vivo clinical isolates cannot be accounted for. However, the fact that the normalised expression values are distributed within the range observed for laboratory-adapted and cultured clinical lines indicates that these genes are unlikely to exhibit expression levels more extreme than the cultured lines. These data emphasise the value of laboratory-adapted and cultured clinical lines as models for ex vivo parasite isolates.
Discussion
Variations in gene expression contribute to the adaptation strategies of many organisms, and influence . Extensive whole-genome sequencing projects have shown that parasites respond to selective pressure through genetic sequence-level variations, which is particularly relevant for genes expressed at the schizont-stage. However, the extent to which transcriptional variation might lead to alterations in phenotypes such as growth adaptation and antigenic variation has not been studied.
Here, we have used highly replicated whole-transcriptome analyses to study variations in gene expression between schizont-stage malaria parasite isolates.
Many transcriptomic analyses perform optimally with increased levels of sample replication to minimise the impact of stochastic differences in transcription [22, 54] . This is particularly important for studies that focus on a defined transcriptional window such as the schizont stage, in which noise is generated due to subtle stage-dependent differences between samples. However, the nature of ex vivo clinical samples of malaria parasites is such that replication is technically very difficult, and may be impossible. In order to assess the degree of replication necessary to robustly identify differentially expressed genes, we have used laboratory-adapted isolates samples with ten replicates to calculate the true-and false-discovery rates obtained using fewer replicates. In keeping with studies in S.
cerevisiae [22] , we have shown in P. falciparum that increasing the sample replication improves the true-positive discovery rate. We conclude that where possible, six independent replicates per isolate optimally balances gene discovery and experimental feasibility. When only fewer replicates were included in the analysis, we found that focussing on genes that are more highly expressed improves the discovery rate.
The highly variable nature of epigenetically-regulated genes in P. falciparum will add to the apparent gene-wise variation observed among cloned parasite samples. The cultured clinical lines under study here had not been previously cloned and it is likely that the isolates will contain multiple parasite genotypes [55] . Consequently, we expect the effect of clonally-variant gene expression on overall gene-wise variation to be minimised. It has been proposed that spontaneous transcriptional variation within genetically identical malaria parasite populations is a strategy that ensures fitness of parasites facing a range of potential and changing selective pressures [3] . It is likely that the rates that genes are up-or down-regulated by these mechanisms differ on a gene-by-gene basis. Therefore, bulk analysis of cloned lines will always be confounded by transcriptional heterogeneity. The recent adaption of single-cell transcriptomics methods to P. falciparum parasites will allow the definition of population-wide transcriptomic profiles [56, 57] . Application of these methods to ex vivo clinical isolates is essential to understand the diversity of antigen expression in vivo.
We addressed the effect of undescribed sequence polymorphisms on transcriptome analysis, by refining and masking 'non-mapping' transcript regions prior to transcriptome analysis, rather than removing polymorphic genes altogether. As earlier observed [19] , our comparisons among isolates highlighted how gene copy-number variations impact the observed transcriptional differences among lines, highlighting the importance of, where possible, generating appropriate reference genomes for inter-isolate transcriptomic comparisons.
In a broad comparison of laboratory-adapted strains and cultured clinical isolates, we found that among the genes most strongly differentially expressed were genes involved in sexual differentiation, and potential transcription factors, which may play a role in transcriptional differences between longterm adapted laboratory isolates and recently cultured clinical lines. Of particular interest were genes encoding an AP2-transcription factor [58] and two methyltransferases, the roles of which remain to be investigated in P. falciparum. The over-representation of gametocyte-related genes differentially expressed between the two groups may reflect a lesser state of adaptation to culture within the cultured clinical isolates, and as such these isolates may commit to gametocytogenesis at a higher rate.
This was also a feature of pan-lifecycle transcriptome comparisons of laboratory-adapted and field
isolates [2] . Studies of gametocytogenesis in clinical isolates will provide a wealth of information on the process of commitment to sexual differentiation and transmission.
In general, differentially expressed genes were repressed in the cultured clinical isolates, suggesting that transcription is more relaxed in laboratory lines. HP1 is responsible for extensive gene silencing in malaria parasites [43] . We showed that there was an over representation of HP1-regulated genes among the genes differentially expressed between laboratory and cultured clinical isolate, although further studies are required to determine whether HP1 strictly determines gene expression in clinical isolates.
Through pairwise comparisons of individual cultured clinical isolates, we identified many genes that were differentially expressed among clinical isolates. Many of the genes identified have previously been shown to be differentially expressed through targeted qRT-PCR assays of schizont-stage ex vivo clinical isolate material [11, 18, 19] . In order to focus on transcriptional variation as a mechanism of immune evasion, we identified a panel of eight highly differentially expressed genes that encode secreted proteins, since these may be targets of immunity. In particular, PF3D7_0102700 (merozoiteassociated tryptophan-rich antigen), PF3D7_0220000 (liver stage antigen 3) have both been identified as merozoite proteins [48, 49] . Another gene identified in out study, PF3D7_0423900, sits near the genes encoding cysteine-rich protective antigen (CyRPA) and reticulocyte binding homolog 5 (PfRh5) on chromosome 4. Differential expression of PF3D7_0423900 has not before been of all participating children, and additional assent was received from children over 10 years old.
Antimalarial treatment and care was provided according to the Ghana Health Service guidelines.
Venous blood samples (up to 5 ml) were collected into heparinized Vacutainer tubes (BD Biosciences). Blood samples were centrifuged, plasma and leukocyte buffy coats were removed, and erythrocytes were cryopreserved in glycerolyte and stored frozen at −80°C or in liquid nitrogen until shipment on dry ice to the London School of Hygiene and Tropical Medicine. A summary of clinical samples included in this study is shown in S6 Table. Parasite culture and maintenance.
Parasites from thawed, ex vivo clinical samples were cultured at 2 % hematocrit in RPMI 1640 medium containing 2 % human AB serum (GE Healthcare) and 0.3 % Albumax II (Thermo Fisher Scientific) under an atmosphere of 5 % O 2 , 5 % CO 2 , and 90 % N 2 at 37 °C. Following thaw, parasites were matured for up to 48 h in until most parasites were at the schizont stage of parasite development, at which point RNA was extracted directly from the bulk cultures.
Laboratory-adapted and long-term cultured clinical isolates were cultured at 2 -5 % haematocrit in RPMI 1640 medium containing 0.5 % Albumax II, at 37 °C. Laboratory-adapted isolates were cultured under atmospheric air with 5 % CO 2 , and cultured clinical isolates were cultured in 5 % O 2 , 5 % CO 2 , and 90 % N 2 . Schizonts were isolated from cultured lines by either MACS or discontinuous density centrifugation methods. For MACS purification of cultured clinical isolates, late stage parasites were isolated from 100 ml cultures with at least 0.7 % schizonts. For MACS purification of laboratory lines 3D7 and Dd2, 25 ml cultures with at least 1 % schizonts were used. Parasites were isolated by magnetic purification using magnetic LD Separation columns (Miltenyi Biotech). One column was used per 25 ml culture. Columns were washed twice in 3 ml of room temperature culture medium. Parasite culture was pelleted at 500 x g for 5 minutes. The pellet was resuspended in 3 ml culture medium per 1 ml of packed cell volume. The resuspended material was bound to the MACS column, which was then washed three times with 3 ml culture medium. Schizonts were eluted twice by removing the magnet from the column and forcing 2 ml culture medium through the column into a 15 ml falcon. Finally, the schizonts were pelleted at 500 g for 5 minutes and the pellet volume was estimated. 0.5 µl was harvested for giemsa-stained smear to assess staging, and 1 µl was added back to 250 µl culture at 0.8 % hematocrit to follow the progression. Remaining parasites were resuspended in 1.5 ml of culture medium with 10 µM E64 in a 12 well plate. Parasites were incubated for 5.5 hours in 5 % CO 2 at 37 °C, before pelleting in a 1.5 ml tube and proceeding with RNA extraction.
For discontinuous density centrifugation purification, parasites were maintained as 25 ml cultures at 2.5 % hematocrit. Cultures were used when they contained at least 1 % parasites with multiple nuclei.
Schizonts were purified on a discontinuous density gradient. Specifically, 70 % Percoll (GE Healthcare)/2.93 % sorbitol/PBS was overlaid with 35 % Percoll/1.47 % sorbitol/PBS, which was in turn overlaid with resuspended pRBCs. Schizonts were separated by centrifugation at 2500 g for 10 minutes at 24 °C, with a light break. Purified schizonts were washed once in complete medium and the pellet volume was estimated. Six pellet volumes of 50 % haematocrit erythrocytes were added to the pellet and resuspended. The sample was smeared, and resuspended in 6 ml of complete culture medium. Of this, 1 ml was used as a control untreated sample to track parasite egress. E64 was added to the remaining 5 ml at a final conentraction of 10 µM. Control and E64-treated samples were placed at 37 °C, 5 % CO 2 static incubator for 5.5 hours. Schizonts from the E64-treated culture were overlaid on 70 % Percoll/2.93 % sorbitol/PBS and separated by centrifugation at 2500 g for 10 minutes at 24 °C, with a light break. The schizont layer was washed once in complete culture medium and final pellets yielding 10 -20 µl packed material were used for RNA extraction.
RNA extraction.
Pellets were resuspended 500 µl in Ex vivo isolate RNA-seq libraries were prepared using a modified protocol. PolyA+ RNA (mRNA) was selected using magnetic oligo-d(T) beads. mRNA was reverse transcribed using Superscript III® (Thermo Fisher Scientific), primed using oligo-d(T) primers. dUTP was included during secondstrand cDNA synthesis. The resulting double stranded cDNA was fragmented using a Covaris AFA sonicator. Sheared double stranded cDNA was dA-tailed, end repaired, and "PCR-free" barcoded sequencing adaptors (Bioo Scientific) [60] were ligated (NEB). Libraries were cleaned up twice, using solid phase reversible immobilisation beads, and eluted in EB buffer (Qiagen). Second strand cDNA was removed using uracil-specific excision reagent enzyme mix (NEB). Libraries were quantified by quantitative PCR prior to sequencing on an Illumina MiSeq sequencer.
Data handling.
Raw sequence reads were aligned to the P. falciparum 3D7 v3 genome and converted to 'bam' format using samtools [61] . Reads with MAPQ scores < 60 were removed. Reads were counted using the "summarizeOverlaps" feature of the GenomicAlignments package [62] in R, against a previously published P. falciparum genome annotation file that had been masked for regions of polymorphism (detailed in S2 File) to remove known regions of genomic polymorphism, highly polymorphic gene families and duplicated genes.
Data curation and analysis.
Fragments Per Kilobase of transcript per Million mapped reads (FPKMs) for our own data and that of 
Data open access
Laboratory-adapted and cultured clinical RNA-seq data are submitted for access via Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/), entry: GSE113718.
Ex vivo RNA-seq data are submitted for access via the European Nucleotide Accession Archive (https://www.ebi.ac.uk/ena), study: ERP103955. Figure 1 Increased replication improves discovery of differentially expressed genes. Boxplot of the true-positive (1 and 2) and false-positive (3 and 4) rates for comparisons of 3D7 and D10 strains using two, four, six or eight replicates, compared to ten-replicate comparisons. 1 and 3 depict rates calculated for comparisons of 3D7 and D10 strains, with all differentially expressed genes considered.
2 and 4 depict rates calculated for differentially expressed genes among the top quartile of expression levels for comparisons of 3D7 and D10 strains. Histogram of fold changes (in any comparison of six clinical isolates) for genes in the top quartile of FPKM expression values. Genes that satisfy an absolute log 2 fold change >2 and adjusted P-value < 0.01 are highlighted in orange; b. Plot of log 2 maximum FPKM expression value for genes in the top quartile of expression values, against the mean absolute log 2 fold change for 15 pairwise comparisons of six clinical isolates. Genes that satisfy an absolute log 2 fold change >2 and adjusted P-value < 0.01 are highlighted in orange; c. Plot of maximum and mean absolute log 2 fold changes in expression in comparisons of six clinical isolates, for genes within the top quartile log 2 FPKM expression values.
Genes that satisfy an absolute log 2 fold change >2 and adjusted P-value < 0.01 are highlighted in orange. 
